Table 3 Logistic regression model of factors that predicted for receiving chemotherapy
From: Role of a multidisciplinary team in administering radiotherapy for esophageal cancer
Variables | OR | 95% CI | P |
|---|---|---|---|
Age(y) | P = 0.176 | ||
< 60 | 1.00 | ||
60–75 | 3.57 | 0.93–13.75 | P = 0.064 |
≥ 75 | 2.27 | 0.75–6.83 | P = 0.147 |
Sex | |||
Male | 1.00 | ||
Female | 0.32 | 0.12–0.83 | P = 0.020 |
PS | |||
0–1 | 1.00 | ||
2–3 | 0.14 | 0.04–0.52 | P = 0.006 |
Location | |||
Neck-Upper | 1.00 | ||
Middle-Lower | 0.72 | 0.25–2.11 | P = 0.546 |
Histologic type | |||
SCC | 1.00 | ||
Adeno or others | 0.50 | 0.12–2.03 | P = 0.334 |
Stage | P = 0.113 | ||
I-II | 1.00 | ||
III | 2.75 | 1.06–7.11 | P = 0.037 |
IV | 2.22 | 0.36–13.83 | P = 0.394 |
Differentiation | P = 0.088 | ||
I-II | 1.00 | ||
III-IV | 3.86 | 1.16–12.84 | P = 0.028 |
unknown | 1.73 | 0.47–6.37 | P = 0.408 |
Treatment modality | |||
non-operation | 1.00 | ||
With operation | 1.29 | 0.33–5.07 | P = 0.719 |
non-MDT | 1.00 | ||
With MDT | 3.03 | 1.29–7.08 | P = 0.011 |